EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Teneurin C‐Terminal Associated Peptide ( TCAP )‐1 Attenuates Restraint Stress‐Induced Corticosterone Increases in Male Mice and Rats

Lauren E Mueller iD, Roseanne S Wexler, David A Lovejoy, Robert B Stein, Andrew M Slee

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Lauren E Mueller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Protagenic Therapeutics Inc., New York, New York, USA. Hauptthemen laut MEDLINE: Corticosterone, Restraint, Physical, Stress, Psychological, Administration, Intranasal. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperactivation of the hypothalamic‐pituitary‐adrenal (HPA) axis response can result in anxiety and other neuropsychiatric disorders and effective therapeutics are needed to mitigate this maladaptive response. Here we examined the effects of Teneurin C‐terminal Associated Peptide (TCAP)‐1, a peptide known to inhibit corticotropin releasing factor (CRF)‐mediated stress, on the physiological expression of stress, and whether the effects of TCAP‐1 were dependent on the route of administration. We first examined whether subcutaneous administration of TCAP‐1 influenced tube restraint stress‐induced corticosterone (CORT) increases in both male mice and rats. Using a similar model, we further examined the efficacy and time course of intranasal TCAP‐1. Results showed that subcutaneous TCAP‐1 administration attenuated the expression of the physiological manifestation of stress in male mice and rats, and that intranasal TCAP‐1 delivered prophylactically is effective at attenuating stress‐induced CORT increases in male rats. These data indicate that TCAP‐1 delivered though non‐invasive routes of administration could have potential as a clinically relevant anxiolytic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CorticosteroneRestraint, PhysicalStress, PsychologicalAdministration, IntranasalAnimalsMaleRatsMiceHypothalamo-Hypophyseal SystemRats, Sprague-DawleyPituitary-Adrenal SystemInjections, SubcutaneousCorticotropin-Releasing HormoneMice, Inbred C57BLNerve Tissue Proteins

Substanzen

CorticosteroneTCAP-1 protein, mouseCorticotropin-Releasing HormoneNerve Tissue Proteins

Autor:innen und Institutionen

  • Protagenic Therapeutics Inc., New York, New York, USA.
  • NeoSome Life Science, Lexington, Massachusetts, USA.
  • Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Lauren E Mueller

Zitieren

APA

Mueller, L. E., Wexler, R. S., Lovejoy, D. A., Stein, R. B., & Slee, A. M. (2024). Teneurin C‐Terminal Associated Peptide ( TCAP )‐1 Attenuates Restraint Stress‐Induced Corticosterone Increases in Male Mice and Rats. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70045

Vancouver

Mueller LE, Wexler RS, Lovejoy DA, Stein RB, Slee AM. Teneurin C‐Terminal Associated Peptide ( TCAP )‐1 Attenuates Restraint Stress‐Induced Corticosterone Increases in Male Mice and Rats. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.70045

BibTeX
@article{Mueller2024,
  author = {Mueller, Lauren E and Wexler, Roseanne S and Lovejoy, David A and Stein, Robert B and Slee, Andrew M},
  title = {Teneurin C‐Terminal Associated Peptide ( TCAP )‐1 Attenuates Restraint Stress‐Induced Corticosterone Increases in Male Mice and Rats},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.70045}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche